AKT1 and glioblastoma: Allen et al. could induce TRAIN expression in mice models with GBM significantly by deploying a novel TRAIL-inducing compound 10 (TIC10), and this mechanism was attributed to stimulant inhibition of Akt and ERK signaling pathways and subsequent transcriptional activity promotion of FOXO3a by TIC10 [197].